Chris Gibson

Angel

Overview

Gender
male
Investor Type
Angel

Chris Gibson is the Co-Founder and CEO of Recursion (Recursion Pharmaceuticals). He previously worked at Cure HHT as a Member Board of Directors. Chris Gibson attended the University of Utah.

Personal Investments

Number of Investments
2
Chris Gibson has made 2 investments. Their most recent investment was on Aug 11, 2020, when Enveda Biosciences raised $4.90M.
Date Company Name Round Money Raised Industry
Jun 22, 2021 Enveda Biosciences Series A $51M Biotechnology Detail
Aug 11, 2020 Enveda Biosciences Seed $4.90M Biotechnology Detail